Clinical Trial Update: Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy [Phase 3]

View source ↗

Summary

Phase 3 open-label trial of NPO-11 in patients undergoing therapeutic upper GI endoscopy has completed, evaluating gastric cancer and colorectal tubular adenoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Tubular Adenoma
• Gastric Adenoma
• Gastric Cancer

Drugs mentioned

• NPO-11 (NPO-11)

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Gastric Cancer, Colon Nos Polypectomy Tubular Adenoma | Phase 3 | Status: COMPLETED